Article

Sequential monotherapy yields poor results in CPPS

Sequential monotherapy yields poor results in CPPS

Related Videos
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Expert discusses genitourinary syndrome of menopause guidelines
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Anna Myers, CNP, answers a question during a Zoom video interview
Urology CNP discusses sensitivity in communication, physical exam
Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
Urologist discusses drug cost savings, price transparency
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
Raymond Xu, MD, answers a question during a Zoom video interview
Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
Related Content
National Women’s Health Week: Celebrating women shaping the future of urology
May 12th 2025

National Women’s Health Week: Celebrating women shaping the future of urology

Shaya Taghechian, MD Hannah Clarke
"I’m hopeful because women in urology are no longer an exception—they’re becoming the norm," says Shaya Taghechian, MD.
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
April 29th 2025

Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

Amy M. Pearlman, MD Rachel Rubin, MD
Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.
FDA updates in urology: March 2025
April 1st 2025

FDA updates in urology: March 2025

Hannah Clarke
A recap of the FDA submissions and regulatory decisions in urology from March 2025.
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
April 28th 2025

Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

Melissa Kaufman, MD, PhD, FACS
In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
March 25th 2025

Expert discusses unique mechanism of action of UTI treatment gepotidacin

Ryan Haumschild, PharmD, MS, MBA, CPEL
"I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.
FDA approves gepotidacin for uncomplicated UTI
March 25th 2025

FDA approves gepotidacin for uncomplicated UTI

Hannah Clarke
The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.
© 2025 MJH Life Sciences

All rights reserved.